Chemical Structure : Oclacitinib
CAS No.: 1208319-26-9
Catalog No.: PC-22617Not For Human Use, Lab Use Only.
Oclacitinib (PF-03394197) is a potent JAK inhibitor with IC50 of 10, 18, 99, and 84 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $88 | In stock | |
25 mg | $148 | In stock | |
50 mg | $248 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Oclacitinib (PF-03394197) is a potent JAK inhibitor with IC50 of 10, 18, 99, and 84 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Oclacitinib (PF-03394197) does not significantly inhibit a panel of 38 other kinases when tested at 1 uM.
Oclacitinib (PF-03394197) inhibits IL-2, IL-4, IL-6, IL-13, and IL-31 with IC50's ranging from 36 to 249 nM, much less potent against erythropoietin and GM-CSF.
Oclacitinib (PF-03394197) inhibited JAK1-dependent cytokine receptor complexes involved in inflammation and pruritus, common clinical signs in canine allergic skin disease.
M.Wt | 337.44 | |
Formula | C15H23N5O2S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide |
1. Fukuyama T, et al. Eur J Pharmacol. 2017 Jan 5;794:20-26.
2. Panteri A, et al. Vet Dermatol. 2016 Feb;27(1):22-e7.
3. Gonzales AJ, et al. J Vet Pharmacol Ther. 2014 Aug;37(4):317-24.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright